HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Patrick Roth Selected Research

Mega-Fas-ligand

2/2011APO010, a synthetic hexameric CD95 ligand, induces human glioma cell death in vitro and in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Patrick Roth Research Topics

Disease

52Glioblastoma (Glioblastoma Multiforme)
04/2022 - 04/2006
51Neoplasms (Cancer)
10/2022 - 11/2009
40Glioma (Gliomas)
05/2022 - 04/2006
12Brain Neoplasms (Brain Tumor)
01/2022 - 12/2010
10Lymphoma (Lymphomas)
06/2021 - 05/2010
5Seizures (Absence Seizure)
06/2021 - 04/2014
4Epilepsy (Aura)
01/2020 - 04/2014
3Neoplasm Metastasis (Metastasis)
10/2022 - 11/2013
3Ependymoma
08/2021 - 04/2016
2Multiple Myeloma
10/2020 - 07/2015
2Virus Diseases (Viral Diseases)
01/2020 - 10/2017
2Inflammation (Inflammations)
09/2019 - 02/2019
2B-Cell Lymphoma (Lymphoma, B Cell)
07/2015 - 01/2014
2Edema (Dropsy)
11/2013 - 12/2010
1Venous Thromboembolism
01/2022
1Astrocytoma (Pilocytic Astrocytoma)
08/2021
1Brain Diseases (Brain Disorder)
06/2021
1Wounds and Injuries (Trauma)
01/2021
1Necrosis
10/2020
1Hematologic Neoplasms (Hematological Malignancy)
10/2020
1Disease Progression
01/2020

Drug/Important Bio-Agent (IBA)

21Temozolomide (Temodar)FDA LinkGeneric
05/2022 - 03/2009
13Proteins (Proteins, Gene)FDA Link
01/2021 - 04/2006
12Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
01/2022 - 12/2011
8Messenger RNA (mRNA)IBA
12/2019 - 04/2006
7MethyltransferasesIBA
01/2021 - 04/2014
7Bevacizumab (Avastin)FDA Link
01/2021 - 10/2014
7LigandsIBA
12/2019 - 11/2009
6Transforming Growth Factors (Transforming Growth Factor)IBA
01/2022 - 02/2013
6DNA (Deoxyribonucleic Acid)IBA
01/2021 - 04/2014
6Biomarkers (Surrogate Marker)IBA
01/2021 - 08/2011
5Biological ProductsIBA
01/2021 - 10/2014
5CytokinesIBA
10/2020 - 04/2014
5InterferonsIBA
01/2020 - 09/2012
5MicroRNAs (MicroRNA)IBA
12/2016 - 08/2011
5IntegrinsIBA
07/2016 - 02/2013
4Pharmaceutical PreparationsIBA
10/2020 - 04/2014
4AntigensIBA
01/2018 - 01/2012
3NivolumabIBA
04/2022 - 01/2017
3Immune Checkpoint InhibitorsIBA
06/2021 - 06/2017
3O-(6)-methylguanineIBA
01/2021 - 04/2014
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2020 - 11/2009
3EpitopesIBA
10/2020 - 01/2018
3SteroidsIBA
01/2020 - 12/2010
3Alkylating AgentsIBA
01/2018 - 04/2014
3CilengitideIBA
03/2016 - 02/2013
3Anticonvulsants (Antiepileptic Drugs)IBA
03/2016 - 04/2014
3CaspasesIBA
04/2014 - 11/2009
2Phosphotransferases (Kinase)IBA
01/2022 - 11/2019
2vinyltriethoxysilane (VTES)IBA
01/2022 - 01/2020
2Chimeric Antigen ReceptorsIBA
06/2021 - 01/2018
2Telomerase (Telomerase Reverse Transcriptase)IBA
01/2021 - 11/2015
2Proteasome Endopeptidase Complex (Proteasome)IBA
10/2020 - 11/2009
2Antisense OligonucleotidesIBA
12/2019 - 01/2017
2ErbB Receptors (EGF Receptor)IBA
11/2019 - 10/2014
2Liposomes (Liposome)IBA
10/2019 - 01/2018
2Peptides (Polypeptides)IBA
01/2018 - 02/2013
2Small Interfering RNA (siRNA)IBA
10/2017 - 08/2010
2Methotrexate (Mexate)FDA LinkGeneric
09/2017 - 07/2015
2Protein Isoforms (Isoforms)IBA
01/2017 - 11/2013
2Levetiracetam (Keppra)FDA LinkGeneric
03/2016 - 04/2014
2Growth Differentiation Factor 15IBA
02/2016 - 08/2010
2ImmunosorbentsIBA
01/2016 - 08/2010
2EnzymesIBA
01/2016 - 08/2010
2Angiogenesis InhibitorsIBA
11/2015 - 02/2013
2Monoclonal AntibodiesIBA
07/2015 - 11/2013
2Adrenal Cortex Hormones (Corticosteroids)IBA
03/2015 - 12/2010
2Lomustine (CCNU)FDA Link
10/2014 - 12/2013
2Fas Ligand Protein (Fas Ligand)IBA
02/2011 - 11/2009
1Activin Receptors (Activin Receptor)IBA
01/2022
1AnticoagulantsIBA
01/2022
1infigratinibIBA
01/2022
1Lenalidomide (CC 5013)FDA Link
06/2021
1Thalidomide (Thalomid)FDA Link
06/2021
1Toll-Like Receptors (Toll-Like Receptor)IBA
06/2021
1Agammaglobulinaemia Tyrosine KinaseIBA
06/2021
1NF-kappa B (NF-kB)IBA
06/2021
1pomalidomideIBA
06/2021
1ibrutinibIBA
06/2021
1Bispecific AntibodiesIBA
06/2021
1Antisense RNA (Anti-Sense RNA)IBA
01/2021
1Protein Glutamine gamma Glutamyltransferase 2IBA
01/2021
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021
1Long Noncoding RNAIBA
01/2021
1Fibronectins (Fibronectin)IBA
10/2020
1Interleukin-12 (IL 12)IBA
10/2020
1Interleukin-2 (IL2)IBA
10/2020
1Bortezomib (Velcade)FDA Link
10/2020
1Proteasome InhibitorsIBA
10/2020
1marizomibIBA
10/2020
1Antidepressive Agents (Antidepressants)IBA
10/2020

Therapy/Procedure

29Therapeutics
10/2021 - 03/2009
24Drug Therapy (Chemotherapy)
08/2021 - 03/2009
21Radiotherapy
04/2022 - 12/2012
12Immunotherapy
06/2021 - 08/2010
8Chemoradiotherapy
01/2022 - 11/2015
2Aftercare (After-Treatment)
10/2022 - 01/2019
1Catheters
01/2021
1Intravenous Administration
10/2020
1Terminal Care (Care, Terminal)
05/2020